The University of Chicago Header Logo

Connection

Edward Naureckas to Antibodies, Monoclonal

Back to Details
This is a "connection" page, showing publications Edward Naureckas has written about Antibodies, Monoclonal.
Edward Naureckas
Connection Strength
0.018
Antibodies, Monoclonal
  1. Efficacy Results of a 52-week Trial of Adalimumab in the Treatment of Refractory Sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 2014 Apr 18; 31(1):46-54.
    View in: PubMed
    Score: 0.018
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.